Key molecular targets, such as <i>EGFR</i>, <i>PTEN</i>, <i>TP53</i>, <i>NF1</i> and PIK3CA, are discussed within the context of GBM's mutational and signaling landscape. The gene discussed is TP53; the disease is glioblastoma.